Familial aggregation in giant cell arteritis and polymyalgia rheumatica: a comprehensive literature review including 4 new families

被引:0
|
作者
Liozon, E. [1 ]
Ouattara, B. [1 ]
Rhaiem, K. [1 ]
Ly, K. [1 ]
Bezanahary, H. [1 ]
Loustaud, V. [1 ]
Letellier, P. [3 ]
Drouet, M. [2 ]
Vidal, E. [1 ]
机构
[1] Dupuytren Univ Hosp, Dept Internal Med, Limoges, France
[2] Dupuytren Univ Hosp, Immunol & Immunogenet Labs, Limoges, France
[3] Univ Hosp, Dept Internal Med & Clin Immunol, Caen, France
关键词
giant cell arteritis; polymyalgia rheumatica; familial aggregation; genetic factors; environmental factors; POLYMERASE-CHAIN-REACTION; VARICELLA-ZOSTER-VIRUS; TEMPORAL ARTERITIS; CHLAMYDIA-PNEUMONIAE; PARVOVIRUS B19; NORTHWESTERN SPAIN; BIOPSY SPECIMENS; HORTONS DISEASE; OLMSTED COUNTY; MARRIED COUPLE;
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective. To review personal and published observations of giant cell (temporal) arteritis (GCA) or polymyalgia rheumatica (PMR) with familial or conjugal aggregation and emphasise on epidemiological, clinical and genetic features of such cases. Methods. We pooled data obtained front all cases of GCA or PMR with familial aggregation recruited in the department since 1976 and those from reports of familial or conjugal GCA or PMR published in the French-English literature since 1970. Results. During the study period, we diagnosed 460 patients (128 with isolated PMR, 22 7 with isolated GCA, 105 with PMR/CGA). No conjugal couples were observed it? the whole series. No familial cases were identified among PMR patients, whereas the prevalence of familial GCA was I in 83 (1 in 250 to 500 expected by chance), as we identified 4 patients (brother-brother, sister with history of affected sister, and daughter with prior), affected mother). An additional pair of sisters with TA, recruited several months after diagnosis, is also presented. Pooling data from 85 patients (74 with GCA) including our patients, representing 32 families and 8 conjugal pairs, enabled its to draw the following observations: 1) partial or full agreement in the clinical picture (GCA, PMR, or GCA/PMR) was observed in 96% of the siblings pairs, suggesting a common pathogenic mechanism; 2)five kindred were described in whom at least three members were affected; 3) the lag between manifested diseases in familial or conjugal pairs averaged 5.7 years, with synchronous or close disease occurrence in only 26% of the pairs; 4) 18 of 32 assessed patients (56%) carried the DR4 antigen. Conclusion. Our survey on familial aggregation of GCA and PMR accumulated data pointing to a genetic predisposition. However, environmental contagious factors could have trigger synchronous disease onset in lip to one-fourth of the cases.
引用
收藏
页码:S89 / S94
页数:6
相关论文
共 50 条
  • [41] GIANT-CELL ARTERITIS AND POLYMYALGIA RHEUMATICA
    SPIERA, H
    HOSPITAL PRACTICE, 1990, 25 (11): : 71 - &
  • [42] POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS
    SCHOEN, R
    ZEITSCHRIFT FUR RHEUMAFORSCHUNG, 1971, 30 (11-1): : 324 - +
  • [43] Polymyalgia rheumatica and giant-cell arteritis
    Putschky, N
    Zeidler, H
    INTERNIST, 1997, 38 (09): : 887 - 897
  • [44] Epidemiology of Giant Cell Arteritis and Polymyalgia Rheumatica
    Gonzalez-Gay, Miguel A.
    Vazquez-Rodriguez, Tomas R.
    Lopez-Diaz, Maria J.
    Miranda-Filloy, Jose A.
    Gonzalez-Juanatey, Carlos
    Martin, Javier
    Llorca, Javier
    ARTHRITIS CARE & RESEARCH, 2009, 61 (10) : 1454 - 1461
  • [45] Giant-Cell Arteritis and Polymyalgia Rheumatica
    Sherwin, Justin C.
    De Smit, Elisabeth
    Hewitt, Alex W.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (17): : 1652 - 1652
  • [46] Giant-Cell Arteritis and Polymyalgia Rheumatica
    Weyand, Cornelia M.
    Goronzy, Joerg J.
    NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (01): : 50 - 57
  • [47] POLYMYALGIA RHEUMATICA AND GIANT-CELL ARTERITIS
    JIPP, P
    FEHRING, K
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 1984, 109 (43) : 1635 - 1638
  • [48] Giant Cell Arteritis and Polymyalgia Rheumatica: an Update
    Miguel A. González-Gay
    Trinitario Pina
    Current Rheumatology Reports, 2015, 17
  • [49] Managing of giant cell arteritis and polymyalgia rheumatica
    Gonzalez-Gay, Miguel A.
    Castaneda, Santos
    EXPERT OPINION ON ORPHAN DRUGS, 2016, 4 (11): : 1133 - 1144
  • [50] Immunopathways in giant cell arteritis and polymyalgia rheumatica
    Weyand, CM
    Ma-Krupa, W
    Goronzy, JJ
    AUTOIMMUNITY REVIEWS, 2004, 3 (01) : 46 - 53